The United States has just experienced its deadliest day on record due to the coronavirus as states across the country begin to ease restrictions meant to curb the spread of the virus, according to data released by the World Health Organization.
The United States has seen 2,909 people die from Covid-19 in 24 hours, according to data, which was collected at 4 a.m. ET on Friday. This is the highest daily death toll from Covid-19 in the United States to date, based on a CNBC analysis of the WHO Daily Reports on the Covid-19 situation.
Prior to May 1, the second highest daily death toll in the United States was 2,471 reported on April 23, according to the WHO. State officials have previously warned that data on Covid-19 deaths is difficult to analyze because it often represents patients who fell ill and were hospitalized weeks ago.
WHO officials did not immediately respond to CNBC’s request for comment.
The country’s deadliest day comes as state officials assess reopening parts of the economy and relaxing stay-at-home orders. Public health officials and epidemiologists have warned that as the public tires of the restrictions and businesses reopen, the virus could spread quickly in communities that have yet to experience a major outbreak.
Protesters in at least 10 states on Friday demanded that the government lift stay-at-home orders and other emergency measures put in place to slow the spread of the coronavirus. States that have seen protests include California, Colorado, Delaware, Florida, Illinois, New Jersey, New Mexico, New York, Tennessee and Washington.
Dozens of states have unveiled plans to reopen and several, including Georgia, South Carolina, Tennessee and Texas, have already started allowing non-essential retailers to reopen.
New York State, which has reported more than 27% of all confirmed cases in the United States, according to data compiled by Johns Hopkins University, has so far been the most affected by the outbreak in the states. -United. The state has reported at least 24,039 of the 65,173 deaths from Covid-19, according to Hopkins.
The death toll of the deadliest day of Covid-19 in the United States rivals that of the attacks of September 11, 2001, which claimed the lives of 2,973 people in one day, according to a government commission.
WHO data differs from data collected by the United States Centers for Disease Control and Prevention, which does not report historical daily deaths from Covid-19. The CDC website says 2,349 people died in the United States from Covid-19 on May 1.
However, the agency warns that its data may not be complete. CDC spokeswoman Kate Grusich told CNBC the agency’s data was “validated through a confirmation process with the courts.”
“The CDC does not know the exact number of illnesses, hospitalizations and deaths linked to COVID-19 for various reasons,” the agency said, adding that asymptomatic patients, notification delays and limited testing make it difficult accurate data tracking.
Some cities, like New York, have struggled to fully understand the death toll from Covid-19. Many patients die at home and others are attributed to heart attacks or other conditions that may have been exacerbated by Covid-19, New York Mayor Bill de Blasio said last month.
To further complicate the system for reporting Covid-19 deaths, the mortuary system in hard-hit cities like New York is overwhelmed by the influx of victims. Funeral homes, caught in the middle of the bottleneck, had to store the corpses in refrigerated trucks, or in some cases any storage unit they could find.
The CDC warns that all data is currently “provisional” and that the agency may not have a more accurate count until December of next year.
The United States Food and Drug Administration has granted emergency use authorization for Gilead Sciences’ drug remdesivir to treat Covid-19, President Donald Trump announced on Friday.
The EUA means remdesivir has not undergone the same level of review as an FDA-approved treatment, according to an agency’s fact sheet on the drug. However, doctors will be allowed to use the drug on patients hospitalized for the disease even if the drug has not been officially approved by the agency.
The intravenous drug has shortened the recovery time of some hospitalized Covid-19 patients, new clinical trial data suggest. Without other proven treatments, healthcare workers will likely consider its use.
The FDA had previously cleared the emergency use of the antimalarial drugs chloroquine and hydroxychloroquine to treat Covid-19. However, he later issued a warning against taking the drugs outside of a hospital or formal clinical trial setting after learning of reports of “serious heart rhythm problems” in patients. .
Under the EUA, the FDA will allow the drug to be administered for a five-day or 10-day dose. A 10-day regimen is preferable for intubated patients.
“This will allow Gilead to effectively double the supply,” former FDA commissioner Scott Gottlieb said in an interview on CNBC’s “Closing Bell”.
The company said it will continue to support clinical trials and expand compassionate use programs for remdesivir.
– CNBC’s Berkeley Lovelace, Yelena Dzhanova and Hannah Miller contributed to this report.